Some months ago I had an interaction with Allie Beatty, a writer for www.thediabetesblog.com. She threw a curve at me concerning the significance of c-peptide in control of type 1 diabetes. I approached several insurance and reinsurance companies to see if they had ever considered considering c-peptide levels in their underwriting for type 1 diabetes. [...]
Read...Related Headlines
- Nationwide v. Leonard: Fifth Circuit upholds anti-concurrent cause provision as unambiguousposted 247 weeks ago on Insurance Coverage Blog
- Fifth Circuit hears arguments in Leonard v. Nationwide Katrina appealposted 250 weeks ago on Insurance Coverage Blog
- More on Northrop Grumman v. Factory Mutualposted 247 weeks ago on Insurance Coverage Blog
- In Re Katrina Canal Breaches Litigation: More on Fifth Circuit's decision, did the Court hint how it will go on Tuepker?posted 251 weeks ago on Insurance Coverage Blog
- Commentary on Fifth Circuit's decision in Tuepker v. State Farmposted 237 weeks ago on Insurance Coverage Blog
- Louisiana Fourth Circuit finds flood exclusion ambiguousposted 235 weeks ago on Insurance Coverage Blog
-
Louisiana Fourth Circuit finds flood exclusion ambiguous
posted 235 weeks ago on Insurance Coverage Blog
- State Farm, homeowners settle Katrina case in Mississippi state courtposted 241 weeks ago on Insurance Coverage Blog
-
Reaction to Sher case
posted 215 weeks ago on Insurance Coverage Blog
-
Reaction to Sher cases
posted 215 weeks ago on Insurance Coverage Blog